We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRMB:NYSEPrimo Brands Corporation Analysis

Data as of 2026-04-25 - not real-time

$20.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Primo Brands is trading around $20.4, which is nearly double its DCF‑derived fair value of $11.2, implying a market premium of roughly 28% despite a trailing P/E of 97 and a forward P/E of 13. Revenue growth of 11% and a modest operating margin of 7% are being priced in, while the company carries a heavy debt load of $5.7 bn against just $0.38 bn in cash, yielding a debt‑to‑equity ratio above 190. Free cash flow remains positive at $0.44 bn, but the dividend payout ratio exceeds 190%, raising questions about the sustainability of the 2.35% yield. Recent news of a $3.09 bn refinancing term loan and an analyst upgrade to Buy with a $25 price target suggest improving capital structure and optimism on earnings momentum. Technically, the stock sits below its 20‑day SMA (19.56) and 50‑day SMA (19.93) but above the 200‑day SMA (20.86), with a bullish MACD histogram and an RSI near 56, indicating limited short‑term overbought pressure. However, volume trends are decreasing and the broader trend direction is flagged as bearish, with the price testing a support level around $17.88 and facing resistance near $21.33. High 30‑day volatility (~44%) and a beta of 0.65 point to moderate market sensitivity, while the max drawdown of over 56% underscores historical downside risk. The defensive consumer sector provides a cushion, but regulatory scrutiny on water quality and environmental standards adds a medium‑level risk. Overall, the stock appears priced for growth expectations that may be overstated given the balance‑sheet strain and dividend sustainability concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical trend with decreasing volume
  • Current price above DCF fair value
  • High valuation multiples (trailing P/E 97)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Refinancing term loan improves balance‑sheet flexibility
  • Analyst upgrade to Buy and price target of $25
  • Forward P/E compression to 13 suggesting earnings upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Defensive consumer sector provides stability
  • Sustainable cash flow but high debt burden
  • Dividend payout ratio above earnings raises sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth11.20%
Profit Margin0.90%
P/E Ratio97.1
ROE2.50%
ROA4.09%
Debt/Equity191.31
P/B Ratio2.5
Op. Cash Flow$687.4M
Free Cash Flow$436.9M

Technical Analysis

TrendBearish
RSI55.9
Support$17.88
Resistance$21.33
MA 20$19.56
MA 50$19.93
MA 200$20.86
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

Fair Value$11.21
Target Price$26.08
Upside/Downside27.86%
GradeOvervalued
TypeGrowth
Dividend Yield2.35%

Risk Assessment

Beta0.65
Volatility43.90%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.